Importantly, in recent years, mounting pieces of evidence suggest that GSH adducts, controlled by glutaredoxins (Glrxs) as a redox switch, participate in various human diseases including cancer to cardiovascular diseases.14, 15. This evidence concerns the gene GLRX and cancer.